IRIS-PREMIER REGISTRY

Seung-Jung Park

Status: Completed

Conditions: Coronary Artery Disease; Myocardial Ischemia; Heart Diseases; Coronary Disease

Treatments: Device: Promus PREMIER

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT02060968

AMCCV2014-03

Details and patient eligibility

About

The purpose of this study is to evaluate effectiveness and safety of Promus PREMIER in Routine Clinical Practice

Enrollment: 2,006 patients

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 20 and more
• Intervention with Promus PREMIER everolimus eluting coronary stent
• Agreed with written informed consent form

Exclusion criteria

• Intervention with Promus PREMIER everolimus eluting coronary stent and other drug eluting stent at the same time
• Life expectancy of 1year and under
• Cardiac shock

Trial design

2,006 participants in 1 patient group

IRIS PREMIER Cohort

Description:

Promus PREMIER

Treatment:

Device: Promus PREMIER